160 related articles for article (PubMed ID: 30271587)
1. MED19 encodes two unique protein isoforms that confer prostate cancer growth under low androgen through distinct gene expression programs.
Ruoff R; Weber H; Wang Y; Huang H; Shapiro E; Fenyö D; Garabedian MJ
Sci Rep; 2023 Oct; 13(1):18227. PubMed ID: 37880276
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel androgen-responsive genes by sequencing of LongSAGE libraries.
Romanuik TL; Wang G; Holt RA; Jones SJ; Marra MA; Sadar MD
BMC Genomics; 2009 Oct; 10():476. PubMed ID: 19832994
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome-wide landscape of pre-mRNA alternative splicing associated with metastatic colonization.
Lu ZX; Huang Q; Park JW; Shen S; Lin L; Tokheim CJ; Henry MD; Xing Y
Mol Cancer Res; 2015 Feb; 13(2):305-18. PubMed ID: 25274489
[TBL] [Abstract][Full Text] [Related]
4. Androgens and prostate disease.
Cooper LA; Page ST
Asian J Androl; 2014; 16(2):248-55. PubMed ID: 24407178
[TBL] [Abstract][Full Text] [Related]
5. Alternative RNA splicing modulates ribosomal composition and determines the spatial phenotype of glioblastoma cells.
Larionova TD; Bastola S; Aksinina TE; Anufrieva KS; Wang J; Shender VO; Andreev DE; Kovalenko TF; Arapidi GP; Shnaider PV; Kazakova AN; Latyshev YA; Tatarskiy VV; Shtil AA; Moreau P; Giraud F; Li C; Wang Y; Rubtsova MP; Dontsova OA; Condro M; Ellingson BM; Shakhparonov MI; Kornblum HI; Nakano I; Pavlyukov MS
Nat Cell Biol; 2022 Oct; 24(10):1541-1557. PubMed ID: 36192632
[TBL] [Abstract][Full Text] [Related]
6. Gene ontology analysis for RNA-seq: accounting for selection bias.
Young MD; Wakefield MJ; Smyth GK; Oshlack A
Genome Biol; 2010; 11(2):R14. PubMed ID: 20132535
[TBL] [Abstract][Full Text] [Related]
7. Thirteen years to get from b to a: one of the neglected isoforms of IL-37 enters the stage.
Cho SX; Rudloff I; Ellisdon AM; Nold-Petry CA; Nold MF
Cell Mol Immunol; 2024 Feb; 21(2):201-202. PubMed ID: 38105292
[No Abstract] [Full Text] [Related]
8. psichomics: graphical application for alternative splicing quantification and analysis.
Saraiva-Agostinho N; Barbosa-Morais NL
Nucleic Acids Res; 2019 Jan; 47(2):e7. PubMed ID: 30277515
[TBL] [Abstract][Full Text] [Related]
9. MAPK1/3 kinase-dependent ULK1 degradation attenuates mitophagy and promotes breast cancer bone metastasis.
Deng R; Zhang HL; Huang JH; Cai RZ; Wang Y; Chen YH; Hu BX; Ye ZP; Li ZL; Mai J; Huang Y; Li X; Peng XD; Feng GK; Li JD; Tang J; Zhu XF
Autophagy; 2021 Oct; 17(10):3011-3029. PubMed ID: 33213267
[TBL] [Abstract][Full Text] [Related]
10. Restricted effects of androgens on glucocorticoid signaling in the mouse prefrontal cortex and midbrain.
Amaya JM; Sips HCM; Viho EMG; Kroon J; Meijer OC
Front Endocrinol (Lausanne); 2023; 14():1292024. PubMed ID: 38303978
[TBL] [Abstract][Full Text] [Related]
11. Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer.
Advani R; Luzzi S; Scott E; Dalgliesh C; Weischenfeldt J; Munkley J; Elliott DJ
Oncogene; 2023 Oct; 42(43):3161-3168. PubMed ID: 37752235
[TBL] [Abstract][Full Text] [Related]
12. Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer.
Mazumder S; Mitra Ghosh T; Mukherjee UK; Chakravarti S; Amiri F; Waliagha RS; Hemmati F; Mistriotis P; Ahmed S; Elhussin I; Salam AB; Dean-Colomb W; Yates C; Arnold RD; Mitra AK
Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497496
[TBL] [Abstract][Full Text] [Related]
13. Transcript-targeted analysis reveals isoform alterations and double-hop fusions in breast cancer.
Namba S; Ueno T; Kojima S; Kobayashi K; Kawase K; Tanaka Y; Inoue S; Kishigami F; Kawashima S; Maeda N; Ogawa T; Hazama S; Togashi Y; Ando M; Shiraishi Y; Mano H; Kawazu M
Commun Biol; 2021 Nov; 4(1):1320. PubMed ID: 34811492
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor and its splice variant, AR-V7, differentially induce mRNA splicing in prostate cancer cells.
Rana M; Dong J; Robertson MJ; Basil P; Coarfa C; Weigel NL
Sci Rep; 2021 Jan; 11(1):1393. PubMed ID: 33446905
[TBL] [Abstract][Full Text] [Related]
15. Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis.
Wang G; Anastassiou D
Sci Rep; 2020 Oct; 10(1):17199. PubMed ID: 33057153
[TBL] [Abstract][Full Text] [Related]
16. Androgen-regulated transcription of
Munkley J; Li L; Krishnan SRG; Hysenaj G; Scott E; Dalgliesh C; Oo HZ; Maia TM; Cheung K; Ehrmann I; Livermore KE; Zielinska H; Thompson O; Knight B; McCullagh P; McGrath J; Crundwell M; Harries LW; Daugaard M; Cockell S; Barbosa-Morais NL; Oltean S; Elliott DJ
Elife; 2019 Sep; 8():. PubMed ID: 31478829
[TBL] [Abstract][Full Text] [Related]
17. Androgen-dependent alternative mRNA isoform expression in prostate cancer cells.
Munkley J; Maia TM; Ibarluzea N; Livermore KE; Vodak D; Ehrmann I; James K; Rajan P; Barbosa-Morais NL; Elliott DJ
F1000Res; 2018; 7():1189. PubMed ID: 30271587
[No Abstract] [Full Text] [Related]
18. Identification of novel androgen-regulated pathways and mRNA isoforms through genome-wide exon-specific profiling of the LNCaP transcriptome.
Rajan P; Dalgliesh C; Carling PJ; Buist T; Zhang C; Grellscheid SN; Armstrong K; Stockley J; Simillion C; Gaughan L; Kalna G; Zhang MQ; Robson CN; Leung HY; Elliott DJ
PLoS One; 2011; 6(12):e29088. PubMed ID: 22194994
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
